Juvenile onset autoinflammatory disease due to a novel mutation in TNFAIP3 (A20)

Juvenile onset autoinflammatory disease due to a novel mutation in TNFAIP3 (A20)

Bibliographic Details
Main Authors:	Shuzo Sato, Yuya Fujita, Tomonari Shigemura, Hisanori Matoba, Kazunaga Agematsu, Yuya Sumichika, Makiko Yashiro, Atsushi Ono, Yukihiko Kawasaki, Hiroko Kobayashi, Hiroshi Watanabe, Tomohiro Koga, Atsushi Kawakami, Kiyoshi Migita
Format:	Article
Language:	English
Published:	BMC 2018-12-01
Series:	Arthritis Research & Therapy
Online Access:	http://link.springer.com/article/10.1186/s13075-018-1766-x

Similar Items

Autoinflammatory disease: clinical perspectives and therapeutic strategies
by: Atsushi Kawakami, et al.
Published: (2022-12-01)

Correction: Autoinflammatory disease: clinical perspectives and therapeutic strategies
by: Atsushi Kawakami, et al.
Published: (2022-12-01)

Interleukin-6 inhibition in the treatment of autoinflammatory diseases
by: Tomohiro Koga, et al.
Published: (2022-07-01)

Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils
by: Makiko Yashiro Furuya, et al.
Published: (2018-08-01)

Elevated serum levels of checkpoint molecules in patients with adult Still’s disease
by: Yuya Fujita, et al.
Published: (2020-07-01)

Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils
by: Yuya Fujita, et al.
Published: (2019-11-01)

Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients
by: Yuya Fujita, et al.
Published: (2020-04-01)

JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
by: Yuya Fujita, et al.
Published: (2020-06-01)

Cold-inducible RNA-binding protein (CIRP) potentiates uric acid-induced IL-1β production
by: Yuya Fujita, et al.
Published: (2021-04-01)

Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still’s disease
by: Yuya Fujita, et al.
Published: (2021-01-01)

Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
by: Yuya Fujita, et al.
Published: (2021-01-01)

Effectiveness of Colchicine or Canakinumab in Japanese Patients with Familial Mediterranean Fever: A Single-Center Study
by: Shuhei Yoshida, et al.
Published: (2023-09-01)

Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis
by: Haruki Matsumoto, et al.
Published: (2022-12-01)

Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis
by: Shuzo Sato, et al.
Published: (2020-03-01)

Poly (I:C) and hyaluronic acid directly interact with NLRP3, resulting in the assembly of NLRP3 and ASC in a cell-free system
by: Naoe Kaneko, et al.
Published: (2017-08-01)

Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still’s disease and their association with cytokines
by: Shuhei Yoshida, et al.
Published: (2024-04-01)

Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus
by: Tomoyuki Asano, et al.
Published: (2020-11-01)

Real-World Effectiveness of Belimumab in Patients with Active Lupus
by: Yuya Sumichika, et al.
Published: (2023-12-01)

Association between inflammatory cytokines and immune–checkpoint molecule in rheumatoid arthritis
by: Haruki Matsumoto, et al.
Published: (2021-01-01)

Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still’s disease
by: Tomoyuki Asano, et al.
Published: (2018-05-01)

Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse
by: Shuhei Yoshida, et al.
Published: (2023-01-01)

Serum amyloid A induces NLRP-3-mediated IL-1β secretion in neutrophils.
by: Kiyoshi Migita, et al.
Published: (2014-01-01)

Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD)
by: Haruki Matsumoto, et al.
Published: (2021-05-01)

Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
by: Jumpei Temmoku, et al.
Published: (2023-07-01)

Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis
by: Shuhei Yoshida, et al.
Published: (2023-02-01)

Identification of Disease-Promoting HLA Class I and Protective Class II Modifiers in Japanese Patients with Familial Mediterranean Fever.
by: Michio Yasunami, et al.
Published: (2015-01-01)

Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with Therapy-Induced Lymphopenia
by: Jumpei Temmoku, et al.
Published: (2023-07-01)

Safety of JAK and IL-6 inhibitors in patients with rheumatoid arthritis: a multicenter cohort study
by: Shuhei Yoshida, et al.
Published: (2023-10-01)

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis
by: Jumpei Temmoku, et al.
Published: (2022-01-01)

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.
by: Jumpei Temmoku, et al.
Published: (2022-01-01)

Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
by: Naoki Matsuoka, et al.
Published: (2020-01-01)

Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
by: Shuzo Sato, et al.
Published: (2021-08-01)

Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
by: Ochs Hans D, et al.
Published: (2011-07-01)

Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan
by: Yushiro Endo, et al.
Published: (2018-11-01)

TNF-α-induced miR-155 regulates IL-6 signaling in rheumatoid synovial fibroblasts
by: Kiyoshi Migita, et al.
Published: (2017-08-01)

A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumab
by: Yuya Fujita, et al.
Published: (2021-03-01)

Case report: Rapid development of amyloid A amyloidosis in temporal arteritis with SAA1.3 allele; An unusual case of intestinal amyloidosis secondary to temporal arteritis
by: Shuhei Yoshida, et al.
Published: (2023-03-01)

Systemic autoinflammatory disorders: autoinflammatory and autoimmune disorders
by: Young Dae Kim
Published: (2023-10-01)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
by: Carla Gaggiano, et al.
Published: (2022-09-01)

The autoinflammatory diseases
by: Silvia Federici, et al.
Published: (2012-06-01)